183 related articles for article (PubMed ID: 32942283)
1. Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
Green RF; Kumerow MT; Rodriguez JL; Addie S; Beachy SH; Senier L
Public Health Genomics; 2020; 23(5-6):218-229. PubMed ID: 32942283
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
Green RF; Ari M; Kolor K; Dotson WD; Bowen S; Habarta N; Rodriguez JL; Richardson LC; Khoury MJ
Genet Med; 2019 Jan; 21(1):28-37. PubMed ID: 29907802
[TBL] [Abstract][Full Text] [Related]
3. Proposed outcomes measures for state public health genomic programs.
Doyle DL; Clyne M; Rodriguez JL; Cragun DL; Senier L; Hurst G; Chan K; Chambers DA
Genet Med; 2018 Sep; 20(9):995-1003. PubMed ID: 29300382
[TBL] [Abstract][Full Text] [Related]
4. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
Modell SM; Greendale K; Citrin T; Kardia SL
Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
[TBL] [Abstract][Full Text] [Related]
5. The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
Trivers KF; Rodriguez JL; Cox SL; Crane BE; Duquette D
Healthcare (Basel); 2015 Oct; 3(4):948-63. PubMed ID: 27417805
[TBL] [Abstract][Full Text] [Related]
6. Using behaviour change and implementation science to address low referral rates in oncology.
Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N
BMC Health Serv Res; 2018 Nov; 18(1):904. PubMed ID: 30486812
[TBL] [Abstract][Full Text] [Related]
7. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
[TBL] [Abstract][Full Text] [Related]
8. Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
Roberts MC; Mensah GA; Khoury MJ
Ethn Dis; 2019; 29(Suppl 1):187-192. PubMed ID: 30906168
[TBL] [Abstract][Full Text] [Related]
9. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
10. Multilevel research and the challenges of implementing genomic medicine.
Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
[TBL] [Abstract][Full Text] [Related]
12. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.
Morrow A; Hogden E; Kang YJ; Steinberg J; Canfell K; Solomon MJ; Kench JG; Gill AJ; Shaw T; Pachter N; Parkinson B; Wolfenden L; Mitchell G; Macrae F; Tucker K; Taylor N
Trials; 2019 Jun; 20(1):373. PubMed ID: 31221211
[TBL] [Abstract][Full Text] [Related]
13. Developing cancer control capacity in state and local public health agencies.
Meissner HI; Bergner L; Marconi KM
Public Health Rep; 1992; 107(1):15-23. PubMed ID: 1738803
[TBL] [Abstract][Full Text] [Related]
14. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
[TBL] [Abstract][Full Text] [Related]
15. CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
Rodriguez JL; Thomas CC; Massetti GM; Duquette D; Avner L; Iskander J; Khoury MJ; Richardson LC
MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1291-1294. PubMed ID: 27880748
[TBL] [Abstract][Full Text] [Related]
16. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
[TBL] [Abstract][Full Text] [Related]
17. The best practices: use of the guidelines by ten state tobacco control programs.
Mueller NB; Luke DA; Herbers SH; Montgomery TP
Am J Prev Med; 2006 Oct; 31(4):300-6. PubMed ID: 16979454
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of state comprehensive cancer control plans for genomics content.
Laufman JD; Duquette D; Trepanier A
Prev Chronic Dis; 2012; 9():E176. PubMed ID: 23256909
[TBL] [Abstract][Full Text] [Related]
19. Process evaluation of a behaviour change approach to improving clinical practice for detecting hereditary cancer.
Long JC; Winata T; Debono D; Phan-Thien KC; Zhu C; Taylor N
BMC Health Serv Res; 2019 Mar; 19(1):180. PubMed ID: 30894169
[TBL] [Abstract][Full Text] [Related]
20. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
